All Wales Abnormal Liver Blood Tests Pathway

Approximately 15% of all liver blood test panels include at least one abnormality, but determining which of those patients have significant liver disease has been a cause for uncertainty.

It is well recognised that advanced liver disease is usually recognised very late and deaths from liver disease continue to rise.

This programme will guide healthcare professionals to have a more assertive approach to the management of abnormal liver blood tests, recognising advanced disease (including cirrhosis) at a much earlier stage.

Featured
Tutorials
Sub-tutorials
Guidelines
Resources
Assessments

TV Show: Management of Abnormal Liver Blood Tests in Wales

In this episode of the TV show, we are joined by Dr Andrew Yeoman, National Clinical Lead for the Liver Disease Implementation Group and Consultant Hepatologist, to explore some of the challenges we face in practice when managing patients with abnormal liver blood tests.

We also unveil the All-Wales Abnormal Liver Blood Tests pathway, which will make it easier to identify the abnormality, signpost for further investigations, and make a follow up plan for our patients with abnormal liver blood tests.

Mark as Understood